The size of mediastinal lymph nodes and its relation with metastatic involvement: a meta-analysis.
暂无分享,去创建一个
Otto S Hoekstra | I. Riphagen | O. Hoekstra | M. Paul | P. Raijmakers | A. D. de Langen | Adrianus J de Langen | Marinus A Paul | Pieter Raijmakers | Ingrid Riphagen
[1] N. Gupta,et al. Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions. , 2000, Chest.
[2] S. Kristensen,et al. Mediastinal staging of lung cancer. Is mediastinoscopy still essential? , 1995, Danish medical bulletin.
[3] H. Nakata,et al. Computed tomography for preoperative evaluations of lung cancer. , 1986, The Journal of computed tomography.
[4] P. Rocmans,et al. Role of Computed Tomography and Mediastinoscopy in Preoperative Staging of Lung Carcinoma , 1985, Journal of computer assisted tomography.
[5] D. Owens,et al. Test Performance of Positron Emission Tomography and Computed Tomography for Mediastinal Staging in Patients with NonSmall-Cell Lung Cancer , 2003, Annals of Internal Medicine.
[6] E H Moore,et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. , 1992, Radiology.
[7] N. Gupta,et al. Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small ( 3 cm) lymph node lesions. , 2000 .
[8] G. Patterson,et al. The current role of mediastinoscopy in the evaluation of thoracic disease. , 1999, The Journal of thoracic and cardiovascular surgery.
[9] D. Whittlesey,et al. Prospective computed tomographic scanning in the staging of bronchogenic cancer. , 1988, The Journal of thoracic and cardiovascular surgery.
[10] Douglas C McCrory,et al. Noninvasive staging of non-small cell lung cancer: a review of the current evidence. , 2003, Chest.
[11] Y. Onodera,et al. Mediastinal Lymph Node Staging by FDG-PET in Patients with Non-Small Cell Lung Cancer: Analysis of False-Positive FDG-PET Findings , 2003, Respiration.
[12] K. Mori,et al. Diagnosis of mediastinal lymph node metastases in lung cancer. , 1992, Japanese journal of clinical oncology.
[13] J. Izbicki,et al. [The value of computerized tomography and of the surgical assessment for lymph node staging in bronchial carcinoma. A prospective study]. , 1991, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.
[14] M. Bronskill,et al. Mediastinal lymph node metastases from bronchogenic carcinoma: detection with MR imaging and CT. , 1987, Radiology.
[15] F L Bookstein,et al. Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping. , 1985, AJR. American journal of roentgenology.
[16] Kenji Suzuki,et al. Clinical Predictors of N 2 Disease in Non-small Cell Lung Cancer * , 2000 .
[17] H. MacMahon,et al. Regional accuracy of computed tomography of the mediastinum in staging of lung cancer. , 1986, The Journal of thoracic and cardiovascular surgery.
[18] H. Schirrmeister,et al. Lymph node staging in lung cancer using [18F]FDG-PET. , 2004, The Thoracic and cardiovascular surgeon.
[19] H. Libshitz,et al. Roentgenographic evaluation of mediastinal nodes for preoperative assessment in lung cancer. , 1985, Chest.
[20] W. Gross-fengels,et al. Konventionelle Röntgenverfahren und Computertomographie in der Diagnostik der mediastinalen Lymphknotenbeteiligung beim nichtkleinzelligen Bronchuskarzinom , 1992 .
[21] J. Best,et al. A comparison of cobalt (57Co) bleomycin scanning and contrast-enhanced CT scanning for assessment of the mediastinum in lung cancer. , 1990, Chest.
[22] S. Kristensen,et al. Mediastinal staging of non-small-cell lung cancer: computed tomography and cervical mediastinoscopy. , 1995, ORL; journal for oto-rhino-laryngology and its related specialties.
[23] G. Krestin,et al. [Conventional x-ray techniques and computed tomography in the diagnosis of mediastinal lymph node involvement in non-small cell bronchogenic cancer. Which method is reliable?]. , 1992, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.
[24] Y. Nishiwaki,et al. Clinical predictors of N2 disease in non-small cell lung cancer. , 2000, Chest.